{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T05:23:10Z","timestamp":1789968190891,"version":"4.0.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.tips.2004.12.005","type":"journal-article","created":{"date-parts":[[2004,12,28]],"date-time":"2004-12-28T23:59:44Z","timestamp":1104278384000},"page":"88-93","source":"Crossref","is-referenced-by-count":69,"title":["Lipodystrophy associated with highly active anti-retroviral therapy for HIV infection: the adipocyte as a target of anti-retroviral-induced mitochondrial toxicity"],"prefix":"10.1016","volume":"26","author":[{"given":"Francesc","family":"Villarroya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere","family":"Domingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Giralt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2004.12.005_bib1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev.med.55.091902.104412","article-title":"HIV-associated lipodystrophy: pathogenesis, prognosis, treatment, and controversies","volume":"55","author":"Koutkia","year":"2004","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.tips.2004.12.005_bib2","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/00002030-200007070-00002","article-title":"Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection","volume":"14","author":"Mallal","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.tips.2004.12.005_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/135965350100600102","article-title":"Antiretroviral therapy and the lipodystrophy syndrome","volume":"6","author":"John","year":"2001","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.tips.2004.12.005_bib4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/135965350100600301","article-title":"Antiretroviral therapy and the lipodystrophy syndrome, part 2: concepts in aetiopathogenesis","volume":"6","author":"Nolan","year":"2001","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.tips.2004.12.005_bib5","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1001\/jama.289.22.2978","article-title":"Impact of HIV infection and HAART on serum lipids in men","volume":"289","author":"Riddler","year":"2003","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.tips.2004.12.005_bib6","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1101\/gad.14.11.1293","article-title":"Transcriptional regulation of adipogenesis","volume":"14","author":"Rosen","year":"2000","journal-title":"Genes Dev."},{"issue":"Suppl. 4","key":"10.1016\/j.tips.2004.12.005_bib7","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1038\/sj.ijo.0801491","article-title":"Adipose cell apoptosis: death in the energy depot","volume":"24","author":"Sorisky","year":"2000","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.tips.2004.12.005_bib8","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1210\/jc.2004-0395","article-title":"Adipose tissue as an endocrine organ","volume":"89","author":"Kershaw","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tips.2004.12.005_bib9","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0165-6147(03)00132-9","article-title":"Do regional differences in adipocyte biology provide new pathophysiological insights?","volume":"24","author":"Lafontan","year":"2003","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tips.2004.12.005_bib10","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00428-002-0667-0","article-title":"Ultrastructural features of highly active antiretroviral therapy-associated partial lipodystrophy","volume":"441","author":"Lloreta","year":"2002","journal-title":"Virchows Arch."},{"key":"10.1016\/j.tips.2004.12.005_bib11","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1097\/00002030-199911120-00008","article-title":"Subcutaenous adipocyte apoptosis in HIV-1 protease inhibitor-associated lipodystrophy","volume":"13","author":"Domingo","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.tips.2004.12.005_bib12","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1086\/323805","article-title":"Switching to nevirapine decreases insulin levels but does not improve subcutaneous adipocyte apoptosis in patients with highly active antiretroviral therapy-associated lipodystrophy","volume":"184","author":"Domingo","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tips.2004.12.005_bib13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.mito.2004.05.008","article-title":"Role of mitochondria in HIV lipoatrophy: insight into pathogenesis and potential therapies","volume":"4","author":"McComsey","year":"2004","journal-title":"Mitochondrion"},{"key":"10.1016\/j.tips.2004.12.005_bib14","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0140-6736(02)08094-7","article-title":"Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance","volume":"359","author":"Bastard","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.tips.2004.12.005_bib15","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1097\/00002030-200308150-00004","article-title":"Expression of adipogenic transcription factors, peroxisome proliferator-activated receptor gamma co-activator 1, IL-6 and CD45 in subcutaneous adipose tissue in lipodystrophy associated with highly active antiretroviral therapy","volume":"17","author":"Kannisto","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.tips.2004.12.005_bib16","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1210\/jc.2002-021922","article-title":"Circulating concentration of adiponectin and its expression in subcutaneous adipose tissue in patients with highly active antiretroviral therapy-associated lipodystrophy","volume":"88","author":"Sutinen","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tips.2004.12.005_bib17","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1177\/135965350400900412","article-title":"Altered fat differentiation and adipocytokine expression are inter-related and linked to morphological changes and insulin resistance in HIV-1-infected lipodystrophic patients","volume":"9","author":"Jan","year":"2004","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.tips.2004.12.005_bib18","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1097\/00002030-200307040-00011","article-title":"Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy","volume":"17","author":"Vigouroux","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.tips.2004.12.005_bib19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/135965350300800102","article-title":"Adipocyte-derived hormone levels in HIV lipodystrophy","volume":"8","author":"Kosmiski","year":"2003","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.tips.2004.12.005_bib20","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2249.2004.02367.x","article-title":"Low plasma level of adiponectin is associated with stavudine treatment and lipodystrophy in HIV-infected patients","volume":"135","author":"Lindegaard","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.tips.2004.12.005_bib21","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/00042560-200012010-00004","article-title":"Association of severe insulin resistance with both loss of limb fat and elevated serum tumor necrosis factor receptor levels in HIV lipodystrophy","volume":"25","author":"Mynarcik","year":"2000","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.tips.2004.12.005_bib22","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1182\/blood.V95.10.3191","article-title":"Alteration of tumor necrosis factor-alpha T-cell homeostasis following potent antiretroviral therapy: contribution to the development of human immunodeficiency virus-associated lipodystrophy syndrome","volume":"95","author":"Ledru","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.tips.2004.12.005_bib23","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1677\/joe.0.1770351","article-title":"Tumour necrosis factor alpha: a key regulator of adipose tissue mass","volume":"177","author":"Warne","year":"2003","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.tips.2004.12.005_bib24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/135965350400900206","article-title":"Adipocytes targets and actors in the pathogenesis of HIV-associated lipodystrophy and metabolic alterations","volume":"9","author":"Gougeon","year":"2004","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.tips.2004.12.005_bib25","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.2337\/diabetes.50.6.1378","article-title":"The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance","volume":"50","author":"Caron","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.tips.2004.12.005_bib26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00002030-200301030-00005","article-title":"Agent and cell-type specificity in the induction of insulin resistance by HIV protease inhibitors","volume":"17","author":"Ben-Romano","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.tips.2004.12.005_bib27","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S0140-6736(99)06102-4","article-title":"Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy","volume":"354","author":"Brinkman","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.tips.2004.12.005_bib28","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/bies.1152","article-title":"Mitochondria in the pathogenesis of lipodystrophy induced by anti-HIV antiretroviral drugs: actors or bystanders?","volume":"23","author":"Cossarizza","year":"2001","journal-title":"BioEssays"},{"key":"10.1016\/j.tips.2004.12.005_bib29","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/135965350300800509","article-title":"Intracellular disposition and metabolic effects of zidovudine, stavudine and four protease inhibitors in cultured adipocytes","volume":"8","author":"Janneh","year":"2003","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.tips.2004.12.005_bib30","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1097\/00002030-200109280-00009","article-title":"Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy","volume":"15","author":"Shikuma","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.tips.2004.12.005_bib31","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1177\/135965350300800614","article-title":"Contribution of nucleoside-analogue reverse transcriptase inhibitor therapy to lipoatrophy from the population to the cellular level","volume":"8","author":"Nolan","year":"2003","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.tips.2004.12.005_bib32","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1097\/00126334-200412150-00002","article-title":"Up-regulatory mechanisms compensate mitochondrial DNA depletion in asymptomatic individuals receiving stavudine plus didanosine","volume":"37","author":"Miro","year":"2004","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.tips.2004.12.005_bib33","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/00002030-200403260-00015","article-title":"Reduction of mitochondrial DNA content and respiratory chain activity occurs in adipocytes within 6-12 months of commencing nucleoside reverse transcriptase inhibitor therapy","volume":"18","author":"Hammond","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.tips.2004.12.005_bib34","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00042560-200202010-00002","article-title":"Evidence of nucleoside analogue reverse transcriptase inhibitor\u2013associated genetic and structural defects of mitochondria in adipose tissue of HIV-infected patients","volume":"29","author":"Walker","year":"2002","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.tips.2004.12.005_bib35","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00126334-200207010-00002","article-title":"Exposure to dideoxynucleosides is reflected in lowered mitochondrial DNA in subcutaneous fat","volume":"30","author":"Cherry","year":"2002","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"Suppl. 1","key":"10.1016\/j.tips.2004.12.005_bib36","first-page":"S102","article-title":"Involvement of the brown adipocyte in pharmacologically-induced lipomatosis","volume":"28","author":"Rodriguez de la Concepci\u00f3n","year":"2004","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.tips.2004.12.005_bib37","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1097\/00002030-200008180-00024","article-title":"Respiratory chain dysfunction associated with multiple mitochondrial DNA deletions in antiretroviral therapy-related lipodystrophy","volume":"14","author":"Miro","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.tips.2004.12.005_bib38","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1097\/00002030-200109070-00006","article-title":"Mitochondrial involvement in antiretroviral therapy-related lipodystrophy","volume":"15","author":"Zaera","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.tips.2004.12.005_bib39","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/sj.bjp.0701276","article-title":"Effects of zidovudine and zidovudine triphosphate on mitochondrial permeability transition and oxidative phosphorylation","volume":"121","author":"Elimadi","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2004.12.005_bib40","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1128\/MCB.23.3.1085-1094.2003","article-title":"Mitochondrial biogenesis and remodeling during adipogenesis and in response to the insulin sensitizer rosiglitazone","volume":"23","author":"Wilson-Fritch","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.tips.2004.12.005_bib41","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1101\/gad.1213104","article-title":"Effect of a C\/EBP gene replacement on mitochondrial biogenesis in fat cells","volume":"18","author":"Chiu","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.tips.2004.12.005_bib42","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature02517","article-title":"Premature ageing in mice expressing defective mitochondrial DNA polymerase","volume":"429","author":"Trifunovic","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.tips.2004.12.005_bib43","first-page":"L47","article-title":"Effect of tenofovir, zidovudine, and stavudine on adipocyte mitochondrial DNA, viability and lipid metabolism","volume":"8","author":"Flint","year":"2003","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.tips.2004.12.005_bib44","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1177\/135965350300800410","article-title":"Mitochondrial DNA depletion and respiratory chain enzyme deficiencies are present in peripheral blood mononuclear cells of HIV-infected patients with HAART-related lipodystrophy","volume":"8","author":"Miro","year":"2003","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.tips.2004.12.005_bib45","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bbabio.2004.03.013","article-title":"Bioenergetics of mitochondrial diseases associated with mtDNA mutations","volume":"1658","author":"Lenaz","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tips.2004.12.005_bib46","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0009-9120(01)00239-9","article-title":"Sterol regulatory element-binding proteins and reactive oxygen species: potential role in highly-active antiretroviral therapy (HAART)-associated lipodystrophy","volume":"34","author":"Nerurkar","year":"2001","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.tips.2004.12.005_bib47","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0014-5793(03)00862-7","article-title":"Inhibition of preadipocyte proliferation by mitochondrial reactive oxygen species","volume":"550","author":"Carriere","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tips.2004.12.005_bib48","doi-asserted-by":"crossref","first-page":"40462","DOI":"10.1074\/jbc.M407258200","article-title":"Mitochondrial reactive oxygen species control the transcription factor CHOP-10\/GADD153 and adipocyte differentiation: A mechanism for hypoxia-dependent effect","volume":"279","author":"Carriere","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2004.12.005_bib49","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0165-6147(03)00125-1","article-title":"Mitochondrion-mediated apoptosis in HIV-1 infection","volume":"24","author":"Badley","year":"2003","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tips.2004.12.005_bib50","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1152\/physrev.00015.2003","article-title":"Brown adipose tissue: function and physiological significance","volume":"84","author":"Cannon","year":"2004","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.tips.2004.12.005_bib51","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0022-2275(20)37142-X","article-title":"Uncoupling protein gene: quantification of expression levels in adipose tissues of obese and non-obese humans","volume":"38","author":"Oberkofler","year":"1997","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tips.2004.12.005_bib52","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1046\/j.1467-789x.2000.00009.x","article-title":"The human uncoupling protein-1 gene (UCP1): present status and perspectives in obesity research","volume":"1","author":"Del Mar Gonzalez Barroso","year":"2000","journal-title":"Obes. Rev."},{"key":"10.1016\/j.tips.2004.12.005_bib53","doi-asserted-by":"crossref","first-page":"33370","DOI":"10.1074\/jbc.M305235200","article-title":"Acquirement of brown fat cell features by human white adipocytes","volume":"278","author":"Tiraby","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2004.12.005_bib54","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00002030-200101260-00013","article-title":"Lipodystrophy-associated morphological, cholesterol and triglyceride abnormalities in a population-based HIV\/AIDS treatment database","volume":"15","author":"Heath","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.tips.2004.12.005_bib55","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1212\/WNL.51.1.258","article-title":"Familial multiple symmetric lipomatosis associated with the A8344G mutation of mitochondrial DNA","volume":"51","author":"Gamez","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.tips.2004.12.005_bib56","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/00002030-200101260-00028","article-title":"Are \u2018buffalo hump\u2019 syndrome, Madelung's disease and multiple symmetrical lipomatosis variants of the same dysmetabolism?","volume":"15","author":"Urso","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.tips.2004.12.005_bib57","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/00002030-200404090-00018","article-title":"Uncoupling protein 1 gene expression implicates brown adipocytes in highly active antiretroviral therapy-associated lipomatosis","volume":"18","author":"Rodriguez de la Concepcion","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.tips.2004.12.005_bib58","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1006\/bbrc.2000.3828","article-title":"Uncoupling protein-1 mRNA expression in lipomas from patients bearing pathogenic mtDNA mutations","volume":"278","author":"Vila","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tips.2004.12.005_bib59","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/135965350300800409","article-title":"Mitochondrial proliferation, DNA depletion and adipocyte differentiation in subcutaneous adipose tissue of HIV-positive HAART recipients","volume":"8","author":"Pace","year":"2003","journal-title":"Antivir. Ther."},{"issue":"Suppl. 1","key":"10.1016\/j.tips.2004.12.005_bib60","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.2337\/diabetes.53.2007.S130","article-title":"The biology of mitochondrial uncoupling proteins","volume":"53","author":"Rousset","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.tips.2004.12.005_bib61","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1097\/00002030-200110190-00012","article-title":"Fat distribution and metabolic changes are strongly correlated and energy expenditure is increased in the HIV lipodystrophy syndrome","volume":"15","author":"Kosmiski","year":"2001","journal-title":"AIDS"},{"issue":"Suppl. 1","key":"10.1016\/j.tips.2004.12.005_bib62","doi-asserted-by":"crossref","first-page":"225","DOI":"10.33549\/physiolres.930000.53.S225","article-title":"Energy metabolism of adipose tissue\u2013physiological aspects and target in obesity treatment","volume":"53","author":"Kopecky","year":"2004","journal-title":"Physiol. Res."},{"key":"10.1016\/j.tips.2004.12.005_bib63","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.1210\/en.2003-0849","article-title":"Minireview: malonyl CoA, AMP-activated protein kinase, and adiposity","volume":"144","author":"Ruderman","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.tips.2004.12.005_bib64","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.febslet.2004.06.002","article-title":"Possible involvement of AMP-activated protein kinase in obesity resistance induced by respiratory uncoupling in white fat","volume":"569","author":"Matejkova","year":"2004","journal-title":"FEBS Lett."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614704003190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614704003190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T05:53:10Z","timestamp":1682920390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614704003190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0165614704003190"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2004.12.005","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}